Literature DB >> 7000158

Iron binding proteins in selected human peripheral blood cell sets: immunofluorescence.

K Nishiya, J W Chiao, M De Sousa.   

Abstract

Selected populations of human peripheral blood T lymphocytes, B lymphocytes, monocytes and polymorphonuclear cells were examined for their intracellular content of lactoferrin transferrin and ferritin by an indirect immunofluorescence technique. Lactoferrin was found in polymorphs but not in lymphoid cells. Two different lactoferrin staining patterns were observed which we designated 'perinuclear', characterized by a ring of positive material round the nucleus, and cytoplasmic, in which most positive material was distributed in the cytoplasm. The former staining pattern was found in high density polymorphs the latter was associated with low density polymorphs occasionally found contaminating the peripheral blood mononuclear cell suspension. After incubation in vitro, the perinuclear pattern changed to cytoplasmic staining. Transferrin was found in T cells and polymorphs. In contrast, only a few transferrin containing cells were detected in the B cell and monocyte fractions. Following overnight incubation, a halo of positive material was found surrounding T cells stained for transferrin, suggesting that T cells released transferrin during incubation. Ferritin was also found in T cells and adherent cells. Following latex particle ingestion, the intensity of ferritin staining was markedly increased. Only a small proportion of lymphoid cells and monocytes stained for transferrin or ferritin in the total peripheral blood mononuclear cell suspension. The results indicate, therefore, that in response to manipulation procedures used routinely for the selection of human peripheral blood lymphoid cells, detectable amounts of transferrin and ferritin are present in T but not B cells. The fact that T cells are equipped with proteins known to participate in binding and storage of iron may constitute, at least in part, the basis for the contribution of these cells to the regulation of other major biological systems.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000158     DOI: 10.1111/j.1365-2141.1980.tb05962.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

Review 1.  Transferrin receptor: its biological significance.

Authors:  W S May; P Cuatrecasas
Journal:  J Membr Biol       Date:  1985       Impact factor: 1.843

2.  Differential staining of neutrophils and monocytes: surface and cytoplasmic iron-binding proteins.

Authors:  J C Barton; R T Parmley; T W Butler; S E Williamson; M B Lilly; R J Gualtieri; L W Heck
Journal:  Histochem J       Date:  1988-03

Review 3.  Iron in joint inflammation.

Authors:  A J Dabbagh; C W Trenam; C J Morris; D R Blake
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

4.  Tissue preparation for the demonstration of surface antigen by immunoperoxidase techniques.

Authors:  M A Judd; K J Britten
Journal:  Histochem J       Date:  1982-09

5.  Loss of antibody binding to prefixed cells: fixation parameters for immunocytochemistry.

Authors:  W Van Ewijk; P L Van Soest; A Verkerk; J F Jongkind
Journal:  Histochem J       Date:  1984-02

6.  Transferrin synthesis by inducer T lymphocytes.

Authors:  J B Lum; A J Infante; D M Makker; F Yang; B H Bowman
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

Review 7.  Iron overload and immunity.

Authors:  Graça Porto; Maria De Sousa
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

8.  Iron and neoplasia.

Authors:  E D Weinberg
Journal:  Biol Trace Elem Res       Date:  1981-03       Impact factor: 3.738

9.  MRI-based evaluation of multiorgan iron overload is a predictor of adverse outcomes in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  Natalia Maximova; Massimo Gregori; Giulia Boz; Roberto Simeone; Davide Zanon; Giulia Schillani; Floriana Zennaro
Journal:  Oncotarget       Date:  2017-07-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.